Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease

BACKGROUND: The course of autosomal dominant polycystic kidney disease (ADPKD) is often associated with pain, hypertension, and kidney failure. Preclinical studies indicated that vasopressin V(2)-receptor antagonists inhibit cyst growth and slow the decline of kidney function. METHODS: In this phase...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Torres, Vicente E., Chapman, Arlene B., Devuyst, Olivier, Gansevoort, Ron T., Grantham, Jared J., Higashihara, Eiji, Perrone, Ronald D., Krasa, Holly B., Ouyang, John, Czerwiec, Frank S.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2012
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3760207/
https://ncbi.nlm.nih.gov/pubmed/23121377
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1205511
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak